Resources by Therapeutic Area

Resources by Therapeutic Area

Learn about the next-generation Simoa biomarker detection technology that enables researchers to multiplex up to 10 analytes with unprecedented sensitivity.
In an excerpt from a panel discussion which took place at MedCity CONVERGE on July 11, 2018, Quanterix Chairman and CEO Kevin Hrusovsky joins other key innovators to discuss game-changing biotech advancements and the future of healthcare.
We're passionate about the work we do and believe we can transform today’s sick care into tomorrow’s precision healthcare.
Quanterix' proprietary Simoa Bead Technology is based on the isolation of individual immunocomplexes on paramagnetic beads using standard ELISA reagents.